Translate to...

Dr Reddy#39;s expects to launch Remdesivir in August

Dr Reddy#39;s expects to launch Remdesivir in August

On another antivral Favipiravir, which is prescribed for mild COVID-19 cases, Dr Reddy#39;s said it will be going ahead with the product, despite Glenmark#39;s clinical trial data hasn#39;t been statistically significant.